A detailed history of Northwestern Mutual Wealth Management CO transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 2,189 shares of IOVA stock, worth $16,329. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,189
Previous 1,880 16.44%
Holding current value
$16,329
Previous $15,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$7.28 - $11.9 $2,249 - $3,677
309 Added 16.44%
2,189 $20,000
Q2 2022

Aug 04, 2022

BUY
$6.38 - $18.33 $8,294 - $23,828
1,300 Added 224.14%
1,880 $21,000
Q4 2021

Feb 03, 2022

SELL
$16.55 - $27.63 $281 - $469
-17 Reduced 2.85%
580 $11,000
Q3 2021

Nov 15, 2021

BUY
$20.35 - $26.63 $345 - $452
17 Added 2.93%
597 $14,000
Q1 2021

May 14, 2021

BUY
$28.67 - $52.59 $16,628 - $30,502
580 New
580 $18,000

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.18B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Northwestern Mutual Wealth Management CO Portfolio

Follow Northwestern Mutual Wealth Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.